Recent alternative approaches of vascular drug-eluting stents

被引:4
作者
Han C.-M. [1 ]
Park K.-S. [1 ]
Joung Y.K. [1 ,2 ]
机构
[1] Center for Biomaterials, Korea Institute of Science and Technology, Seoul
[2] Division of Bio-Medical Science and Technology, University of Science and Technology (UST), Daejeon
关键词
Anti-inflammation; Drug eluting stent; Re-endothelialization; Restenosis; Thrombosis; Vascular stent;
D O I
10.1007/s40005-017-0378-9
中图分类号
学科分类号
摘要
Vascular stent is tubular shaped medical device designed to treat occluded circulatory or digestive systems by opening the blocked vascular sites. Originally stents were made of bare metals, such as stainless steel and cobalt–chromium alloys, due to their inherent corrosion resistance and good mechanical properties. Damage of intimal layer during expansion of stent, however, have caused neointimal hyperplasia resulting in in-stent restenosis which is one of main complications of vascular stent treatment. Drug-eluting stents (DESs) were introduced to alleviate this restenosis by local delivery of anti-proliferative drugs to the implanted or inserted site. The DES systems have been developed over the years by making changes in its main component, namely, drug, polymeric coating layer and expandable scaffold. Nevertheless, late thrombosis caused by drugs themselves and polymeric coating layer still remains as a serious problem of DES systems. Numerous studies, therefore, consistently focus on more advanced DES systems to solve the current issues. In this mini review article, we cast an opinion on how to improve the potential of DES system by means of (i) summarizing the history of DES system developed so far and (ii) updating current advances for the future generation of DES system. © 2017, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码:153 / 165
页数:12
相关论文
共 105 条
[1]  
Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J., Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury, Circulation, 110, pp. 3300-3305, (2004)
[2]  
Abizaid A., Costa J.R., New drug-eluting stents. An overview on biodegradable and polymer-free next-generation stent systems, Circ Cardiovasc Interv, 3, pp. 384-393, (2010)
[3]  
Acharya G., Park K., Mechanisms of controlled drug release from drug-eluting stents, Adv Drug Deliv Rev, 58, pp. 387-401, (2006)
[4]  
Akin I., Schneider H., Ince H., Kische S., Rehders T.C., Chatterjee T., Nienaber C.A., Second- and third-generation drug-eluting coronary stents: progress and safety, Herz, 36, pp. 190-196, (2011)
[5]  
Anderson J.M., Biological responses to materials, Annu Rev Mater Res, 31, pp. 81-110, (2001)
[6]  
Andukuri A., Min I., Hwang P., Alexander G., Marshall L.E., Berry J.L., Wick T.M., Et al., Evaluation of the effect of expansion and shear stress on a self-assembled endothelium mimicking nanomatrix coating for drug eluting stents in vitro and in vivo, Biofabrication, 6, (2014)
[7]  
Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Et al., Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, pp. 964-966, (1997)
[8]  
Awada H.K., Johnson N.R., Wang Y., Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects, Macromol Biosci, 14, pp. 679-686, (2014)
[9]  
Bedair T.M., Cho Y., Joung Y.K., Han D.K., Biodegradable polymer brush as nanocoupled interface for improving the durability of polymer coating on metal surface, Coll Surf B Biointerfaces, 122, pp. 808-817, (2014)
[10]  
Beijk M.A.M., Klomp M., Verouden N.J.W., van Geloven N., Koch K.T., Henriques J.P.S., Baan J., Et al., Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study, Eur Heart J, 31, pp. 1055-1064, (2010)